MCCOURT Thomas A 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed May 20, 2025
Insider Transaction Report
Form 4
MCCOURT Thomas A
DirectorChief Executive Officer
Transactions
- Sale
Class A Common Stock
2025-05-16$0.58/sh−13,353$7,745→ 1,147,281 total - Award
Class A Common Stock
2025-05-20+540,000→ 1,687,281 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.